Despite the controversy surrounding the Philippines government's importof cheap medicines from India, the Department of Trade and Industry Secretary, Manuel Roxas, has said that several hospitals in the Metro Manila region are already interested in retailing the brands at reasonable prices, the Marketletter's local correspondent reports.
In an interview, Mr Roxas said that the brands imported from India are not only reasonably-priced, they have also passed the tough tests on efficacy and safety of the country's Bureau of Food and Drugs and its counterpart in India. The second batch of drugs from India is currently being distributed to 30 Department of Health hospitals nationwide. Reportedly, eight brands were bought in this second shipment, worth some 20 million pesos ($372,000).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze